These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30471110)

  • 1. Macrophage CD40 signaling drives experimental autoimmune encephalomyelitis.
    Aarts SA; Seijkens TT; Kusters PJ; van Tiel CM; Reiche ME; den Toom M; Beckers L; van Roomen CP; de Winther MP; Kooij G; Lutgens E
    J Pathol; 2019 Apr; 247(4):471-480. PubMed ID: 30471110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of CD40-TRAF6 interactions by the small molecule inhibitor 6877002 reduces neuroinflammation.
    Aarts SABM; Seijkens TTP; Kusters PJH; van der Pol SMA; Zarzycka B; Heijnen PDAM; Beckers L; den Toom M; Gijbels MJJ; Boon L; Weber C; de Vries HE; Nicolaes GAF; Dijkstra CD; Kooij G; Lutgens E
    J Neuroinflammation; 2017 May; 14(1):105. PubMed ID: 28494768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance.
    Chatzigeorgiou A; Seijkens T; Zarzycka B; Engel D; Poggi M; van den Berg S; van den Berg S; Soehnlein O; Winkels H; Beckers L; Lievens D; Driessen A; Kusters P; Biessen E; Garcia-Martin R; Klotzsche-von Ameln A; Gijbels M; Noelle R; Boon L; Hackeng T; Schulte KM; Xu A; Vriend G; Nabuurs S; Chung KJ; Willems van Dijk K; Rensen PC; Gerdes N; de Winther M; Block NL; Schally AV; Weber C; Bornstein SR; Nicolaes G; Chavakis T; Lutgens E
    Proc Natl Acad Sci U S A; 2014 Feb; 111(7):2686-91. PubMed ID: 24492375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerogenic dendritic cells produced by lentiviral-mediated CD40- and interleukin-23p19-specific shRNA can ameliorate experimental autoimmune encephalomyelitis by suppressing T helper type 17 cells.
    Kalantari T; Karimi MH; Ciric B; Yan Y; Rostami A; Kamali-Sarvestani E
    Clin Exp Immunol; 2014 May; 176(2):180-9. PubMed ID: 24387596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages.
    Mukundan L; Bishop GA; Head KZ; Zhang L; Wahl LM; Suttles J
    J Immunol; 2005 Jan; 174(2):1081-90. PubMed ID: 15634933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling.
    Donners MM; Beckers L; Lievens D; Munnix I; Heemskerk J; Janssen BJ; Wijnands E; Cleutjens J; Zernecke A; Weber C; Ahonen CL; Benbow U; Newby AC; Noelle RJ; Daemen MJ; Lutgens E
    Blood; 2008 May; 111(9):4596-604. PubMed ID: 18195092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
    Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
    J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRAF6 and TRAF2/3 Binding Motifs in CD40 Differentially Regulate B Cell Function in T-Dependent Antibody Responses and Dendritic Cell Function in Experimental Autoimmune Encephalomyelitis.
    Lu Y; Chiang J; Zhang R; Roche PA; Hodes RJ
    J Immunol; 2023 Dec; 211(12):1814-1822. PubMed ID: 37921511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPM2 Exacerbates Central Nervous System Inflammation in Experimental Autoimmune Encephalomyelitis by Increasing Production of CXCL2 Chemokines.
    Tsutsui M; Hirase R; Miyamura S; Nagayasu K; Nakagawa T; Mori Y; Shirakawa H; Kaneko S
    J Neurosci; 2018 Sep; 38(39):8484-8495. PubMed ID: 30201769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In acute experimental autoimmune encephalomyelitis, infiltrating macrophages are immune activated, whereas microglia remain immune suppressed.
    Vainchtein ID; Vinet J; Brouwer N; Brendecke S; Biagini G; Biber K; Boddeke HW; Eggen BJ
    Glia; 2014 Oct; 62(10):1724-35. PubMed ID: 24953459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF6 signaling in T cells is crucial for the pathogenicity of experimental autoimmune encephalomyelitis.
    Kamiyama N; Saechue B; Sachi N; Dewayani A; Chalalai T; Ozaka S; Ariki S; Soga Y; Kagoshima Y; Ekronarongchai S; Hidano S; Kobayashi T
    Int Immunol; 2024 Apr; 36(5):241-256. PubMed ID: 38153198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role of CD40 signaling in vascular wall cells in neointimal formation and vascular remodeling after vascular interventions.
    Song Z; Jin R; Yu S; Nanda A; Granger DN; Li G
    Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):50-64. PubMed ID: 21998133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.
    Lutgens E; Lievens D; Beckers L; Wijnands E; Soehnlein O; Zernecke A; Seijkens T; Engel D; Cleutjens J; Keller AM; Naik SH; Boon L; Oufella HA; Mallat Z; Ahonen CL; Noelle RJ; de Winther MP; Daemen MJ; Biessen EA; Weber C
    J Exp Med; 2010 Feb; 207(2):391-404. PubMed ID: 20100871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal pathways in astrocytes activated by cross-talk between of astrocytes and mast cells through CD40-CD40L.
    Kim DY; Hong GU; Ro JY
    J Neuroinflammation; 2011 Mar; 8():25. PubMed ID: 21410936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of CD40-TRAF2,3 or CD40-TRAF6 is sufficient to inhibit pro-inflammatory responses in non-haematopoietic cells.
    Portillo JA; Greene JA; Schwartz I; Subauste MC; Subauste CS
    Immunology; 2015 Jan; 144(1):21-33. PubMed ID: 25051892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
    Moorman CD; Bastian AG; DeOca KB; Mannie MD
    J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).
    Laman JD; van Meurs M; Schellekens MM; de Boer M; Melchers B; Massacesi L; Lassmann H; Claassen E; Hart BA
    J Neuroimmunol; 1998 Jun; 86(1):30-45. PubMed ID: 9655470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system.
    Becher B; Durell BG; Miga AV; Hickey WF; Noelle RJ
    J Exp Med; 2001 Apr; 193(8):967-74. PubMed ID: 11304557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th40 cells (CD4+CD40+ Tcells) drive a more severe form of Experimental Autoimmune Encephalomyelitis than conventional CD4 T cells.
    Vaitaitis GM; Yussman MG; Waid DM; Wagner DH
    PLoS One; 2017; 12(2):e0172037. PubMed ID: 28192476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF receptor-associated factor 6-dependent CD40 signaling primes macrophages to acquire antimicrobial activity in response to TNF-alpha.
    Andrade RM; Wessendarp M; Portillo JA; Yang JQ; Gomez FJ; Durbin JE; Bishop GA; Subauste CS
    J Immunol; 2005 Nov; 175(9):6014-21. PubMed ID: 16237096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.